Metabolic insufficiency underlies intratumoral cytotoxic T cell dysfunction by Tushar Gupta et al.
POSTER PRESENTATION Open Access
Metabolic insufficiency underlies intratumoral
cytotoxic T cell dysfunction
Tushar Gupta, Nicole E Scharping, Rebecca S Moreci, Greg M Delgoffe*
From 30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)
National Harbor, MD, USA. 4-8 November 2015
T cells have the remarkable ability to recognize and
remove abnormal cells with precision, a feature that is
very desirable for the treatment of cancer. However,
while T cells specific for tumor antigens are primed and
can infiltrate tumors, they are quickly rendered dysfunc-
tional, through both cell intrinsic and cell extrinsic
mechanisms. One way that tumors cripple T cell func-
tion is through the generation of an immunosuppressive
microenvironment that is chronically inflamed, hypoxic,
and nutrient poor. T cell activation and subsequent gen-
eration of effector function is bioenergetically demand-
ing, requiring large amounts of metabolic intermediates
to effectively proliferate, produce cytokines, and lyse tar-
get cells. We hypothesized that T cell dysfunction in
cancer is due, in part, to metabolic insufficiency caused
by chronic activation in metabolically dearth conditions.
Using single-cell metabolic assays and extracellular flux
analysis, we show that CD8+ cytotoxic T cells that infil-
trate tumors demonstrate a progressive loss of mitochon-
drial function and mass, concomitant with upregulation
of markers that correlate with T cell exhaustion. This
mitochondrial dysfunction occurs independently of coin-
hibitory molecule signaling and specifically in the tumor
microenvironment. This results in a failure to generate
an adequate pool of ATP and in inability to effectively
translate effector gene transcripts. This in stark contrast
to T cells responding to an acute viral infection, where
activated effector T cells demonstrate increased mito-
chondrial mass and ATP reserve. Further, artificial induc-
tion of mitochondrial dysfunction in T cells results in
upregulation of coinhibitory molecules and an
‘exhausted-like’ phenotype, suggesting that metabolic
insufficiency underlies the dysfunctional phenotype in
cancer. Taken together, our data support a model in
which tumor-infiltrating T cells have metabolic needs
that cannot be met, resulting in failed effector function and
tumor growth. Our studies also suggest that modulation or
reprogramming of the altered metabolism of intratumoral
T cells represents a potential strategy to reinvigorate dys-
functional T cells for the immunotherapeutic treatment of
cancer.
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